Report: Disposable Syringe Markets TOC

1. Introduction

1.1 Statement of Report
1.2 About this Report
1.3 Scope of the Report
1.4 Objectives
1.5 Methodology
1.6 Executive Summary

2. Disposable Syringe Markets

2.1 Overview
2.2 Infection Control and Safety
- 2.2.1 Needlestick Injuries
- 2.2.2 Availability of Safety Syringes in the U.S. Healthcare Facilities
2.3 Cost of Safety Syringe
2.4 Market Expansion
2.5 Unsafe Injection Practices
2.6 Hospital Consolidations Pressure Companies to Reduce Prices
2.7 Strategic Alliance of Needleless Injector Manufacturers
2.8 Technological Advancements in Disposable Syringes
- 2.8.1 Reconstitution inside Sterile Syringes
- 2.8.2 Plungerless Prefilled Syringes
- 2.8.3 The Disposable UniJect™
2.9 Award Winning Syringes
- 2.9.1 Episure AutoDetect Epidural Syringe
- 2.9.2 ConfiDose Disposable Autoinjector
- 2.9.3 Humatrope Reconstitution Device
- 2.9.4 Vasceze Plungerless Syringe

3. Disposable Syringe Market Segments

3.1 Overview
- 3.1.1 World Market for Disposable Syringes
- 3.1.2 U.S. Market for Disposable Syringes
- 3.1.3 Disposable Syringe Market in India

4. Insulin Syringes

4.1 Insulin Strengths: U-40 and U-100
4.2 Market for Insulin Pen
4.3 Shelf Life of Insulin Pen Cartridges
4.4 An Update on Insulin Injection Devices
- 4.4.1 Insulin Injection Devices Currently Available in the U.S.
- 4.4.2 Disposable Pens
- 4.4.3 Refillable Pens
- 4.4.4 Pen Needles
- 4.4.5 Benefits and Patient Preferences
- 4.4.6 Disadvantages of Pen Syringes
- 4.4.7 Insulin Pens and the Hospital Bills
4.5 Insulin Pens for Indian Market from IDC
4.6 Expansion of Facilities for Insulin Pens by Eli Lilly and Rexam
4.7 Major Players in Insulin Pens and Syringes
- 4.7.1 Sanofi-Aventis
  - 4.7.1.1 Sanofi-Aventis' Business in Diabetes Care Segment
- 4.7.2 Novo Nordisk
  - 4.7.2.1 Novo Nordisk' s Diabetes Care Business in North America
  - 4.7.2.2 Novo Nordisk' s International Operations
  - 4.7.2.3 Novo Nordisk' s Business in Diabetes Care in Europe
- 4.7.3 Eli Lilly & Co.
  - 4.7.3.1 Byetta
  - 4.7.3.2 Humulin
  - 4.7.3.3 Humalog

5. Safety Syringes

5.1 Available Safety Syringe Technologies
- 5.1.1 Retrofitted Syringes
- 5.1.2 Automatically Retractable Syringes
- 5.1.3 Manually Retractable Syringes
5.2 Safety Syringe Market
5.3 Drivers of Safety Syringes

6. Prefilled Syringes

6.1 Types of Prefilled Syringes (PFS)
6.2 Market for Prefilled Syringes
6.3 The Rise of Prefilled Syringes
6.4 Needle Safety for Prefilled Syringes
- 6.4.1 V-OVS NS®
- 6.4.2 Preventis™
- 6.4.3 UltraSafe Passive® Delivery System/ERYPROSafe™ and NUFILSafe™
6.5 Sterility Maintenance of Prefilled Syringes
6.6 Compatibility of Drugs with the Components of Prefilled Syringes
6.7 Some of the Drugs Available in Prefilled Syringes
- 6.7.1 Ovidrel® PreFilled Syringe
- 6.7.2 Enbrel Prefilled Syringes
- 6.7.3 Biocon' s Prefilled Safety Syringes
- 6.7.4 Relistor® Prefilled Syringes
- 6.7.5 PEGASYS®
- 6.7.6 Afluria®
- 6.7.7 Enzira®
- 6.7.8 FluZone® Prefilled Syringe for Children
- 6.7.9 Novolin® N FlexPen Prefilled Insulin Syringe
- 6.7.10 NovoLog® Insulin Prefilled Syringe
- 6.7.11 GlaxoSmithKline' s Vaccines in Prefilled Syringes
6.8 U.S. Production of Unilife' s Prefilled Syringes
6.9 Some of the Major Providers of Syringe-Prefilling Services and Products
- 6.9.1 Althea Technologies, Inc.
  - 6.9.1.1 Althea' s Clinical Manufacturing
  - 6.9.1.2 Althea' s Fill/Finish Services
  - 6.9.1.3 Althea' s Contract Manufacturing
- 6.9.2 Baxter International, Inc.
  - 6.9.2.1 Baxter' s Contract Manufacturing
  - 6.9.2.2 Baxter' s Fill and Finish Capabilities
  - 6.9.2.3 Baxter' s Prefilled Syringes Capability
  - 6.9.2.4 Baxter' s Vials
  - 6.9.2.5 Baxter' s Cartridges
- 6.9.3 Becton, Dickinson and Company
  - 6.9.3.1 BD' s Prefilled Syringe Services
  - 6.9.3.2 BD Hypak SCF™ Glass Prefillable Syringes
  - 6.9.3.3 BD Sterifill SCF™ Plastic Prefillable Syringe Systems
  - 6.9.3.4 BD Physioject™ Disposable AutoInjector
  - 6.9.3.5 BD™ MicroInfusor™ Automatic Injection System
  - 6.9.3.6 BD™ Liquid Dry Injector Disposable Pen Injector
  - 6.9.3.7 BD™ Pens Customized Self-Injection Systems
  - 6.9.3.8 BD Soluvia™ Prefillable Microinjection System
  - 6.9.3.9 BD Preventis™ Shielding System for Prefilled Syringes
- 6.9.4 Catalent Pharma Solutions, Inc.
  - 6.9.4.1 The Protector Safety Shield System™
  - 6.9.4.2 The ASI™ Autoinjector and Ultra-Compact ASI Mini™ Autoinjector
- 6.9.5 Hyaluron Contract Manufacturing (HCM)
  - 6.9.5.1 Hyaluron' s Syringe Filling
- 6.9.6 Vetter Pharma Fertigung GmbH
6.10 Features of Prefilled Syringes
- 6.10.1 Dual Chamber Prefilled Syringes

7. Pen Syringes

7.1 Pen Devices for Insulin Delivery
7.2 Technical Advances in Insulin Pens
7.3 Pen Types and Styles
7.4 Prefilled Pens
7.5 Reusable Pens
7.6 Prefilled Autoinjecting Disposable Syringes
7.7 Uniject™ Injection Device

8. Microneedle

8.1 Electronic Mosquito

9. Needle-free Injectors

9.1 Needle-free Delivery of Liquids
9.2 Needle-free Delivery of Solid Formulations
9.3 Needleless Injector from Injex
9.4 Jet Syringe from Injex
9.5 Syrijet
9.6 PenJet
9.7 Needle-free Injector for Human Growth Hormone

10. Needle and Syringe Market Trends

10.1 Market Segments
10.2 Customer Needs
10.3 Competitor Analysis
- 10.3.1 Automatic Safety Syringes
- 10.3.2 Manually Locking Safety Syringes
10.4 Third Party Reimbursement
10.5 Regulation
10.6 Drug Discovery Trends
10.7 Demographic Shifts
10.8 Growth in Home Healthcare

11. Technological Developments

11.1 Auto-Disable Syringes
- 11.1.1 AD Syringes with Needle Retraction/Disposal Feature
- 11.1.2 AD Syringe with No Needle Retraction Feature
- 11.1.3 Needlestick Prevention Syringes
- 11.1.4 Automatic Needlestick Prevention Feature
  - 11.1.4.1 UltraSafe® Passive™ Delivery System
  - 11.1.4.2 Sterimatic Sleeve®
  - 11.1.4.3 K3 Safety Cap
11.2 Manual Needlestick Prevention Feature
- 11.2.1 Safety Lok™ Syringe
- 11.2.2 Monoject® Magellan™

12. Business Trends

12.1 Market Drivers
12.2 Market Prospects
12.3 Marketing and Distribution
12.4 Competitive Landscape
12.5 Future Technologies
- 12.5.1 Glide Solid Dose Injector (SDI™)
- 12.5.2 BD Physioject™

13. Regulatory Measures

13.1 Safety Syringes in Europe

14. Company Profiles

14.1 Abbott Laboratories
- 14.1.1 HUMIRA® Prefilled Syringe
- 14.1.2 HUMIRA® Pen
- 14.1.3 Precision Sure-Dose® Insulin Syringes
14.2 Albert David Limited
14.3 Alshifa Medical Syringes Manufacturing Company Ltd.
14.4 Althea Technologies, Inc.
14.5 Avitro, Inc.
14.6 Baxter International, Inc.
- 14.6.1 Baxter' s Medication Delivery
- 14.6.2 Baxter' s IV Therapies
- 14.6.3 Baxter' s Global Injectables
- 14.6.4 Baxter' s Infusion Systems
- 14.6.5 Baxter' s IV Infusion Pumps and Infusion Sets
- 14.6.6 Baxter' s Pharma Partnering
14.7 Becton, Dickinson and Company (BD)
- 14.7.1 BD' s Role in Designing Devices for Safe and Effective Injections and Infusions
- 14.7.2 BD' s Products
14.8 Boston Scientific Corporation
14.9 B. Braun
- 14.9.1 The Hospital Care Division
- 14.9.2 The Aesculap Division
- 14.9.3 The Out Patient Market (OPM) Division
- 14.9.4 The B. Braun Avitum Division
- 14.9.5 B. Braun' s Syringe Products
14.10 Bioject Medical Technologies, Inc.
- 14.10.1 Biojector® 2000
- 14.10.2 Drug Reconstitution System
- 14.10.3 Vitajet®
- 14.10.4 Cool.click™
- 14.10.5 SeroJet™
14.11 Catalent Pharma Solutions, Inc.
- 14.11.1 Catalent' s Oral Technologies Segment
- 14.11.2 Catalent' s Sterile Technologies Segment
- 14.11.3 Catalent' s Packaging Services Segment
- 14.11.4 Catalent' s Manufacturing Capabilities
- 14.11.5 Catalent' s Employee Strength
- 14.11.6 Catalent' s Syringes
14.12 C.R. Bard, Inc.
- 14.12.1 Bard' s Vascular Business
- 14.12.2 Bard' s Urology Business
- 14.12.3 Bard' s Oncology Business
- 14.12.4 Bard' s Business in Surgical Specialties
- 14.12.5 Bard' s Overseas Expansion
- 14.12.6 Bard' s Bulb Syringes and Trays
- 14.12.7 Bard' s Piston Syringes and Trays
14.13 Coeur, Inc.
- 14.13.1 Angiographic Syringes from Coeur, Inc.
- 14.13.2 CT Syringes from Coeur, Inc.
14.14 Covidien Ltd.
- 14.14.1 Covidien' s Medical Devices Segment
- 14.14.2 Covidien' s R&D
- 14.14.3 Covidien' s Competitors in Medical Devices
- 14.14.4 Covidien' s Syringes
14.15 Henke-Sass, Wolf GmbH
- 14.15.1 Two-Part Disposable Syringes 1-50(60) ml
- 14.15.2 Three-Part Disposable Syringes 1-30 ml
- 14.15.3 Disposable Needles HSW FINE-JECT®
14.16 Hindustan Syringes & Medical Devices, Ltd. (HMD)
- 14.16.1 Insulin Syringes from HMD
- 14.16.2 HMD' s Single Use Needles
- 14.16.3 HMD' s Single Use Syringes
14.17 Hi-Tech Medical Products Ltd.
14.18 Hyaluron Contract Manufacturing
- 14.18.1 HCM' s Major Markets
- 14.18.2 HCM' s Facility
14.19 International Medication System Ltd.
- 14.19.1 Delivery Systems from IMS
- 14.19.2 PCA Products from IMS
- 14.19.3 Phytonadione Injection USP
- 14.19.4 Lidocaine HCl Jelly, USP 2% (Preservative-free)
14.20 Life-Shield Products, Inc.
14.21 Merit Medical Systems, Inc.
- 14.21.1 Merit' s Products
- 14.21.2 Merit' s Vascular Access Products
- 14.21.3 Merit' s Business in the U.S.
- 14.21.4 Merit' s International Business
- 14.21.5 Merit' s Customers
- 14.21.6 Merit' s R&D
- 14.21.7 Merit' s Manufacturing Facilities
14.22 Milestone Scientific
- 14.22.1 Milestone Scientific' s Product Platform
- 14.22.2 Milestone Scientific' s Investment in R&D
- 14.22.3 Milestone Scientific' s Business Performance
14.23 Novo Nordisk A/S
- 14.23.1 Novo Nordisk' s Business in Diabetes Care Segment
- 14.23.2 Novo Nordisk' s Modern Insulins, Human Insulins and Insulin-related Products
- 14.23.3 Novo Nordisk' s Geographic Performance in Diabetes Care Products
- 14.23.4 Pipeline Progress in Nova Nordisk
- 14.23.5 Novo Nordisk' s Modern Insulin Portfolio
14.24 Owen Mumford Ltd.
- 14.24.1 Owen Mumford' s Global Locations
- 14.24.2 Owen Mumford' s Products
14.25 Plas-Pak Industries, Inc.
- 14.25.1 Dial-A-Dose® Disposable Veterinary Syringes
- 14.25.2 Dual Syringe and Dental Syringe from Plas-Pak
- 14.25.3 Mini Dual Syringe
- 14.25.4 Manual Dual Syringes
14.26 Retractable Technologies, Inc.
- 14.26.1 Retractable Technologies' Principal Products
- 14.26.2 Retractable Technologies' Principal Markets
- 14.26.3 Retractable Technologies' R&D
- 14.26.4 Retractable Technologies' VanishPoint Products
14.27 Revolutions Medical Corporation
- 14.27.1 Rev Vac Safety Syringe
14.28 Safety Syringes, Inc.
- 14.28.1 Custom Engineering from Safety Syringes, Inc.
- 14.28.2 Syringe Products from Safety Syringes, Inc.
14.29 Smiths Medical International/Medex, Inc.
- 14.29.1 Smiths Medical' s Markets
- 14.29.2 Smiths Medical' s Medication Delivery Segment
- 14.29.3 Smiths Medical' s Vital Care Segment
- 14.29.4 Smiths Medical' s Safety Devices Segment
- 14.29.5 Smiths Medical' s Business Performance
- 14.29.6 Smiths Medical' s Business Performance on Geographic Basis
- 14.29.7 Smiths Medical' s R&D
- 14.29.8 Syringes from Smiths Medicals
14.30 Specialized Health Products International, Inc.
- 14.30.1 SHPI' s Products and Services
- 14.30.2 SHPI' s Licensed Products
14.31 Star Syringe Ltd.
- 14.31.1 Star Alliances
- 14.31.2 Preoducts from Star Syringe Ltd.
14.32 Terumo' s Medical Corporation
- 14.32.1 Terumo' s General Hospital Products
- 14.32.2 Terumo' s Diabetes Care Products
- 14.32.3 Terumo' s Syringe Products
14.33 UltiMed, Inc.
- 14.33.1 UltiCare™ Insulin Syringes
- 14.33.2 UltiCare™ Pen Needles
14.34 Unilife Medical Solutions, Ltd.
- 14.34.1 Pharmaceutical Market for Unilife' s Prefilled Syringes
- 14.34.2 Unilife Partnership with Sanofi-Aventis
- 14.34.3 Unilife' s Licensing Agreement with Sanofi-Aventis
- 14.34.4 Unilife' s Partnership with Gerresheimer Bunde
- 14.34.5 Unilife' s Portfolio of Safety Syringes
- 14.34.6 Unilife' s Prefilled Syringes
- 14.34.7 Unilife' s Contract Manufacturing Activities
- 14.34.8 Unilife' s Performance in Syringe Market
14.35 Vetter Pharma-Fertigung GmbH & Co., KG
- 14.35.1 Vetter Services and Solutions
- 14.35.2 Dual-Chamber Technology
14.36 Vita Needle Company, Inc.
- 14.36.1 Disposable Stainless Steel Needle Blunts from Vita Needle
- 14.36.2 Teflon® Dispensing Needles
- 14.36.3 Vita Needle' s Polypropylene Needles
- 14.36.4 Vita Needle' s Taper Tip Needles
14.37 West Pharmaceutical Services, Inc.
- 14.37.1 West' s Pharmaceutical Systems Segment
- 14.37.2 West' s Tech Group Segment
- 14.37.3 West' s R&D Activities
- 14.37.4 West' s Syringe Products
14.38 Wuxi Yushou Medical Appliances Co., Ltd.
14.39 Ypsomed Holding AG
- 14.39.1 Ypsomed' s Injection Systems
- 14.39.2 Ypsomed' s Insulin Delivery Systems
- 14.39.3 Additional Indication Areas for Pen Systems
- 14.39.4 Ypsomed' s Innovative Injection Systems at a Glance
- 14.39.5 Ypsomed' s Complete Product Range for Insulin Suppliers
- 14.39.6 Ypsomed' s New Dual-Chamber Injecting Systems
- 14.39.7 Ypsomed' s ServoPen
- 14.39.8 Growth of Ypsomed' s Pen Needles
- 14.39.9 Ypsomed' s Performance in 2008/2009
- 14.39.10 Ypsomed' s R&D
14.40 The Medical House PLC (TMH)
- 14.40.1 TMH' s Products

Appendix 1: U.S. Healthcare Expenditure Projections, 2008-2018

Appendix 2: Syringe Needle Terminology

Appendix 3: Medication Errors and Syringe Safety

Appendix 3.1: Injectable Medication Errors
Appendix 3.2: Frequency of Syringe Usage
Appendix 3.3: Labeling Injectable Medications
Appendix 3.4: Challenges of Labeling
Appendix 3.5: Benefits of a Write-On Stripe
Appendix 3.6: Nurses Influence on Selection of Sharp Devices
Appendix 3.7: Needlestick Injuries
Appendix 3.8: Prevention of Needlestick Injuries
Appendix 3.9: Protection from Needlestick Injuries

INDEX OF FIGURES

Figure 2.1: Principal Causes of Needlestick Injuries
Figure 2.2: Availability of Safety Syringes in the U.S. Healthcare Facilities, 2008
Figure 3.1: Worldwide Unit Market for Syringes and Needles, 2004-2012
Figure 3.2: Global Syringe Market, 2009
Figure 3.3: Worldwide Market for Disposable Syringes and Needles, 2004-2012
Figure 3.4: U.S. Market for Disposable Syringes and Needles, 2006-2013
Figure 3.5: Market Segments of the U.S. Syringe Market, 2009
Figure 3.6: E.U. Market for Syringes, Needles and Catheters, 2007 and 2008
Figure 3.7: Worldwide Market Share for Hypodermic Syringes, 2009
Figure 3.8: Disposable Syringe Market in India, 2008-2012
Figure 3.9: Market Share for Disposable Syringes in India, 2008
Figure 3.10: Market Share for Disposable Needles in India, 2008
Figure 4.1: Market Growth for Insulin Pen, 2007-2014
Figure 4.2: Market Growth for Insulin Pens in Europe, 2007-2014
Figure 4.3: Global Sales Performance of Sanofi-Aventis' Lantus, 2007 and 2008
Figure 4.4: Global Sales Performance of Sanofi-Aventis' Amaryl, 2007 and 2008
Figure 4.5: Sales Performance of Sanofi-Aventis' Lantus by Geography, 2008
Figure 4.6: Novo Nordisk' s Business Performance in Diabetes Care by Geography, 2008
Figure 4.7: Novo Nordisk' s Performance in Diabetes Care, 2004-2008
Figure 4.8: Eli Lilly' s Business Performance in Byetta, 2006 and 2007
Figure 4.9: Eli Lilly' s Business Performance in Humulin, 2006-2008
Figure 4.10: Eli Lilly' s Sales Performance in Humalog, 2006-2008
Figure 5.1: Growth of Safety Syringe Market, 2008-2012
Figure 6.1: Market Growth for Prefilled Syringes, 2009-2013
Figure 6.2: Growth of Prefilled Syringes Market in E.U., 2008-2012
Figure 10.1: Breakdown of U.S. Syringe Market, 2009
Figure 10.2: U.S. Home Healthcare Products Market, 2007-2012
Figure 14.1: Abbott' s Global Business Performance by Country, 2008
Figure 14.2: Abbott' s Global Business Performance, 2004-2008
Figure 14.3: Baxter' s Performance in Medication Delivery Segment, 2008
Figure 14.4: Baxter' s Performance in IV Therapies, 2006-2008
Figure 14.5: Baxter' s Performance in Injectables, 2006-2008
Figure 14.6: Baxter' s Performance in Infusion Systems, 2006-2008
Figure 14.7: BD' s Performance in Safety-engineered Devices, 2007 and 2008
Figure 14.8: BD' s International Performance in Safety-engineered Devices, 2007 and 2008
Figure 14.9: Business Performance by B. Braun' s Hospital Care Division, 2006-2008
Figure 14.10: Business Performance by B. Braun' s Aesculap Division, 2006-2008
Figure 14.11: Business Performance by B. Braun' s Out Patient Market Division, 2006-2008
Figure 14.12: Business Performance by B. Braun' s Avitum Division, 2006-2008
Figure 14.13: B. Braun' s Business Performance by Geographic Region, 2008
Figure 14.14: Share of Bioject' s Business with its Prominent Customers, 2007
Figure 14.15: Bioject' s Business Performance by Product Line, 2007
Figure 14.16: Biotech' s Business Performance in the U.S. and Other Countries, 2007
Figure 14.17: Catalent' s Business Performance, 2004-2008
Figure 14.18: Catalent' s Business Performance in its Oral Technologies Segment, 2007 and 2008
Figure 14.19: Catalent' s Business Performance in its Sterile Technologies Segment, 2007 and 2008
Figure 14.20: Catalent' s Business Performance in its Packaging Services Segment, 2007 and 2008
Figure 14.21: Catalent' s Employee Strength by Region, 2008
Figure 14.22: Bard' s Business Performance in its Vascular Segment, 2004-2008
Figure 14.23: Bard' s Business Performance in its Urology Segment, 2004-2008
Figure 14.24: Bard' s Business Performance in its Oncology Segment, 2004-2008
Figure 14.25: Bard' s Business Performance in its Surgical Specialties Segment, 2004-2008
Figure 14.26: Business Performance of Covidien' s Medical Device Segment, 2006-2008
Figure 14.27: Covidien' s Investment in R&D, 2006-2008
Figure 14.28: Covidien' s Business Performance in Syringes (Sharp Safety Products), 2006-2008
Figure 14.29: Merit' s Business Performance, 2004-2008
Figure 14.30: Merit' s Investment in R&D, 2004-2008
Figure 14.31: Milestone Scientific' s Investment in R&D, 2007 and 2008
Figure 14.32: Milestone Scientific' s Domestic Business Performance, 2007 and 2008
Figure 14.33: Milestone Scientific' s International Business Performance, 2007 and 2008
Figure 14.34: Novo Nordisk' s Sales Performance of Diabetes Care Products, 2004-2008
Figure 14.35: Novo Nordisk' s Sales Performance in Modern Insulins (Insulin Analogues), 2004-2008
Figure 14.36: Retractable Technologies' Business Performance, 2004-2008
Figure 14.37: Retractable Technologies' Domestic Business Performance, 2006-2008
Figure 14.38: Retractable Technologies' International Business Performance, 2006-2008
Figure 14.39: Retractable Technologies' Investment in Research and Expenditure, 2006-2008
Figure 14.40: Smiths Medical' s Business Performance, 2007 and 2008
Figure 14.41: Smiths Medical' s Business Performance by Segment, 2007
Figure 14.42: SHPI' s Sales Performance, 2006 and 2007
Figure 14.43: SHPI' s Revenue from Royalties, 2006 and 2007
Figure 14.44: Terumo' s Business Performance in Prefilled Syringes, 2005-2007
Figure 14.45: Terumo' s Business Performance in Diabetes Care, 2003-2007
Figure 14.46: West' s Business Performance in Pharmaceutical Systems Segment, 2006-2008
Figure 14.47: West' s Business Performance in Tech Group Segment, 2006-2008
Figure 14.48: West' s Investment in R&D in Pharmaceutical Systems Segment, 2006-2008
Figure 14.49: West' s Investment for R&D in Tech Group Segment, 2006-2008
Figure 14.50: Global Prevalence of Diabetes, 2008-2025
Figure 14.51: Prevalence of Diabetes in India, 2008-2025
Figure 14.52: Prevalence of Diabetes in China, 2008-2025
Figure 14.53: Ypsomed' s Sales Performance, 2006/2007 and 2008/2009
Figure 14.54: Ypsomed' s Sales Performance by Geography, 2008/2009
Figure 14.55: Ypsomed' s R&D Expenditure, 2006/2007 and 2008/2009
Figure 14.56: TMH' s Business Performance, 2006-2008
Figure 14.57: TMH' s Business Performance by Geography, 2008
Figure A1.1: National Health Expenditure in the U.S., 2009-2014
Figure A1.2: National Health Expenditure as a Percent of GDP, 2009-2014
Figure A1.3: Health Expenditure Per Capita, 2009-2014
Figure A1.4: Home Healthcare Expenditure, 2009-2014
Figure A1.5: Prescription Drug Expenditure, 2009-2014
Figure A1.6: Other Non-Durable Medical Products Expenditure, 2009-2014
Figure A1.7: Nursing Home Care Expenditure, 2009-2014
Figure A1.8: Dental Service Expenditure, 2009-2014
Figure A1.9: Hospital Care Expenditure, 2009-2014
Figure A1.10: Physician and Clinical Services Expenditure, 2009-2014
Figure A1.11: Personal Healthcare Expenditure, 2009-2014
Figure A3.1: Timing of Needlestick Injuries

INDEX OF TABLES

Table 4.1: Shelf Life of Insulin Pen Cartridges
Table 4.2: Major Insulin Pen Devices Currently Available in the U.S., 2008
Table 10.1: Highlights of Several Leaders in the Disposable Safety Syringe Market
Table 14.1: Albert David' s Syringes with Needles, 2009
Table 14.2: Albert David' s Needles, 2009
Table 14.3: BD' s Auto-Disable Syringes
Table 14.4: Insulin Syringes from BD, 2009
Table 14.5: BD' s Allergy Syringes
Table 14.6: BD' s Tuberculin Syringes
Table 14.7: BD' s Syringes and Needles (Sterile, Single-Use)
Table 14.8: BD' s Safety-Lok™ Safety-Syringes
Table 14.9: BD' s SafetyGlide Syringes
Table 14.10: BD' s Eclipse Syringes
Table 14.11: BD' s Integra Syringes
Table 14.12: BD' s PosiFlush Prefilled Syringes
Table 14.13: Bard' s Piston Syringes and Trays, 2009
Table 14.14: Bard' s Bulb Syringes and Trays, 2009
Table 14.15: Angiographic Syringes from Coeur, Inc., 2009
Table 14.16: CT Syringes from Coeur, Inc., 2009
Table 14.17: HMD' s Dispovan Insulin Syringes, 2009
Table 14.18: HMD' s Single Use Needles, 2009
Table 14.19: HMD' s Single Use Syringes, 2009
Table 14.20: Hi-Tech Single-Use Syringes, 2009
Table 14.21: Hi-Tech' s Single Use Insulin Syringes, 2009
Table 14.22: HCM' s Contract Manufacturing Categories, 2009
Table 14.23: Syringes from IMS, 2009
Table 14.24: PCA Syringe from IMS, 2009
Table 14.25: Phytonadione Injection USP from IMS, 2009
Table 14.26: Lidocaine Prefilled Syringes from IMS, 2009
Table 14.27: Life-Shield' s Syringe Products, 2008
Table 14.28: Autopen Products from Owen Mumford, 2008
Table 14.29: Unifine Products from Owen Mumford, 2008
Table 14.30: Autoject Products from Owen Mumford, 2008
Table 14.31: Retractable Technologies' VanishPoint Syringes, 2009
Table 14.32: Smiths' Pro Fixed Needle TB Syringe, 2009
Table 14.33: Smiths' Needle-Pro® Needle with Needle Protection Device
Table 14.34: Smiths' Needle-Pro® Syringe and Needle with Needle Protection Device, 2009
Table 14.35: Smiths' Needle-Pro® Needle Protection Device for Insulin Injections, 2009
Table 14.36: Smiths' Needle-Pro® Fixed Needle Insulin Syringe
Table 14.37: SurGard2 Syringes with Safety Needle, 2009
Table 14.38: Terumo' s SurGuard2 Safety Needles, 2009
Table 14.39: Terumo' s Hypodermic Needles, 2009
Table 14.40: Terumo' s Hypodermic Syringes without Needle, 2009
Table 14.41: Terumo' s Tuberculin Syringes, 2009
Table 14.42: Terumo' s Hypodermic Syringes with Needle
Table 14.43: Terumo' s SurSaver 1 cc Syringes with Low Dead Space, 2009
Table 14.44: Terumo' s Dental Needles, 2009
Table 14.45: Terumo' s Spinal Needles, 2009
Table 14.46: Terumo' s SurGuard Safety Insulin Syringes, 2009
Table 14.47: Terumo' s Insulin Syringes, 2009
Table 15.48: Thinpro' s Insulin Syringes, 2009
Table 15.49: UltiMed' s UltiCare Insulin Syringes, 2009
Table 14.50: UltiCare Pen Needles, 2009
Table 14.51: Vita Needle' s Stainless Steel Needle Blunts, 2009
Table 14.52: Vita Needle' s Teflon Dispensing Needles, 2009
Table 14.53: Vita Needle' s Polypropylene Needles, 2009
Table 14.54: Vita Needle' s Taper Tip Needles, 2009
Table 14.55: Ypsomed' s Product Roadmap, 2009-2013
Table 14.56: Ypsomed' s Innovative Platforms

Disposable Syringe Markets

Table of Contents

1. Introduction

2. Disposable Syringe Markets

3. Disposable Syringe Market Segments

4. Insulin Syringes

5. Safety Syringes

6. Prefilled Syringes

7. Pen Syringes

8. Microneedle

9. Needle-free Injectors

10. Needle and Syringe Market Trends

11. Technological Developments

12. Business Trends

13. Regulatory Measures

14. Company Profiles

Appendix 1: U.S. Healthcare Expenditure Projections, 2008-2018

Appendix 2: Syringe Needle Terminology

Appendix 3: Medication Errors and Syringe Safety

INDEX OF FIGURES

INDEX OF TABLES